Showing results (421-430 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|December 18, 2019
Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analoguesAshutosh M Shukla, Aparna Wagle ShuklaDrugs in Context|March 12, 2020
Onset of vitiligo following targeted therapy for BRAFV600E-mutated melanoma: case reportSonia Brugnara, Mariacristina Sicher, Elena Maria Bonandini, et al.Drugs in Context|March 12, 2020
Thyrotoxicosis after massive triiodothyronine (LT3) overdose: a coast-to-coast case series and reviewZhiheng H He, Yan Li, Nitin Trivedi, et al.Drugs in Context|March 12, 2020
Efficacy and safety of a GABAergic drug (Gamalate® B6): effects on behavior and cognition in young adults with borderline-to-mild intellectual developmental disabilities and ADHDRamón Novell, Susanna Esteba-Castillo, Emili RodriguezDrugs in Context|March 12, 2020
Management of type 2 diabetes: consensus of diabetes organizationsElaena Quattrocchi, Tamara Goldberg, Nino MarzellaDrugs in Context|October 30, 2020
Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patientsKarel Pavelka, Zoltán Szekanecz, Nemanja Damjanov, et al.Drugs in Context|October 5, 2020
Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL protocolTeodoro Iturbe-Hernandez, Luis García de Guadiana Romualdo, Ignacio Gil Ortega, et al.Drugs in Context|June 11, 2021
Evaluation and treatment of older-age bipolar disorder: a narrative reviewRajesh R Tampi, Pallavi Joshi, Gargi Bhattacharya, et al.Pageof 56